Noteworthy Thursday Option Activity: AKRO, UTI, EL
Stock Options Channel Staff - Thursday, September 28, 3:21 PMAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Akero Therapeutics Inc (AKRO), where a total of 5,316 contracts have traded so far, representing approximately 531,600 underlying shares. That amounts to about 51.6% of AKRO's average daily trading volume over the past month of 1.0 million shares. Especially high volume was seen for the $70 strike call option expiring October 20, 2023, with 2,145 contracts trading so far today, representing approximately 214,500 underlying shares of AKRO. Below is a chart showing AKRO's trailing twelve month trading history, with the $70 strike highlighted in orange:
Universal Technical Institute, Inc. (UTI) saw options trading volume of 612 contracts, representing approximately 61,200 underlying shares or approximately 51.5% of UTI's average daily trading volume over the past month, of 118,805 shares.
Especially high volume was seen for the $7.50 strike call option expiring November 17, 2023, with 610 contracts trading so far today, representing approximately 61,000 underlying shares of UTI. Below is a chart showing UTI's trailing twelve month trading history, with the $7.50 strike highlighted in orange:
And Estee Lauder Cos., Inc. (EL) options are showing a volume of 10,707 contracts thus far today. That number of contracts represents approximately 1.1 million underlying shares, working out to a sizeable 51.2% of EL's average daily trading volume over the past month, of 2.1 million shares.
Particularly high volume was seen for the $165 strike put option expiring October 20, 2023, with 1,992 contracts trading so far today, representing approximately 199,200 underlying shares of EL. Below is a chart showing EL's trailing twelve month trading history, with the $165 strike highlighted in orange:
For the various different available expirations for AKRO options, UTI options, or EL options, visit StockOptionsChannel.com.